COVID-19 Residual Biobank

Overview

About this study

This Research Repository will prospectively collect residual (waste) blood, urine, and stool specimens remaining from clinician order testing and corresponding clinical and patient provided data from COVID-19 patients with confirmed or suspected infection with the novel SARS-CoV-2 virus to enable high quality research.  Participants will be approached for consent by the study team after the samples are identified. Samples and data from this repository will be made available to researchers with IRB-approved research projects after review and approval by the COVID-19 Access Committee.  We believe this biobank will enable high quality research to improve clinical practice and patient outcomes.

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Participation in this Research Repository is by invitation only. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Mayo Clinic patients diagnosed with or suspected to have COVID-19 (infection with SARS-CoV-2).

Exclusion Criteria:

  • None.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Christopher Marquez, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

COVID-19 Biobank (enterprise)

(507) 293-3996

COVID19biobank@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Erin Kaleta, Ph.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

COVID-19 Biobank (enterprise)

(507) 293-3996

COVID19biobank@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Robin Patel, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

COVID-19 Biobank (enterprise)

(507) 293-3996

COVID19biobank@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20489153

Mayo Clinic Footer